SCHEMBL6169513

SCHEMBL6169513

C=CCN1C(=O)C(c2ccc(Cc3ccccc3)cc2)NC1=S

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.48
MAPT P10636 2/20 0.48
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
GAA P10253 6/20 0.41
POLB P06746 3/20 0.41
ALDH1A1 P00352 3/20 0.40
CYP1A2 P05177 3/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2C19 P33261 3/20 0.40
CYP2C9 P11712 2/20 0.40
PKM P14618 1/20 0.39
HTT P42858 1/20 0.38
PAX8 Q06710 1/20 0.38
SIRT1 Q96EB6 1/20 0.38
SIRT5 Q9NXA8 1/20 0.38
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6169897 0.85 SIRT1 (0.55) L3MBTL1MAPTKMT2AMEN1SIRT1
SCHEMBL6167361 0.84 GAA (0.58) MAPTKMT2AMEN1LMNAADORA3
SCHEMBL26948702 0.77 LMNA (0.64) L3MBTL1MAPTLMNAADORA3GAA
SCHEMBL1597896 0.76 GAA (0.70) L3MBTL1MAPTKMT2AMEN1GAA
SCHEMBL6169375 0.72 GAA (0.50) L3MBTL1MAPTKMT2AMEN1LMNA
SCHEMBL19420143 0.72 GAA (0.62) L3MBTL1MAPTKMT2AMEN1GAA
SCHEMBL11017764 0.71 LMNA (0.73) MAPTKMT2ALMNAADORA3GAA
SCHEMBL6167967 0.70 ALDH1A1 (0.52) L3MBTL1MAPTKMT2AMEN1GAA
SCHEMBL26948696 0.70 LMNA (0.46) L3MBTL1MAPTKMT2AMEN1LMNA
SCHEMBL1597383 0.69 MAPT (0.50) L3MBTL1MAPTKMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546111-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2005-06-29 EP disclosed
WO-2004031160-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2004-04-15 WO disclosed